About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Electronic Study for Anastrozole Pharmacovigilance Evaluation

NCT00558168·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

Any age

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Post-menopausal Early Invasive Breast Cancer Patients who are under anastrazole treatment, who have normal renal and hepatic functions.

You may not be if

Metastatic breast cancer patients, previous hormonal therapy, other malignancies.

The record

StatusCompleted

PhaseNo phase

Taking part1,850

StartedJan 2004

UpdatedJul 28, 2008

Conditions

Early Breast Cancer

Clareo Health | Electronic Study for Anastrozole Pharmacovigilance Evaluation